The third and final part of our immunotherapies course is now available. This module includes practical information on the safe handling of monoclonal antibodies, immune related adverse events, patient assessment & monitoring and patient education.
The nursing assessment tool, patient education checklist, triage tool and patient information resource are all in pilot testing and will be released soon.
We are pleased to release the program for our facilitators' forum, on the 21 June 2018 at the Rydges South Bank Brisbane.
We have created an active program with lots of variety and opportunities to engage, learn and network. We are looking forward to meeting you all in Brisbane and sharing a great day together.
Leisa Brown-West is the National Nursing Education Manager for the Icon Group's Australian Division. Leisa has worked within cancer care for 29 years in both the private and public health sector. She currently designs cancer education programs to meet the needs of nursing staff caring for people affected by cancer throughout the Icon Australian network and Singapore.
Leisa is passionate about enabling equitable access to professional development opportunities for health care staff caring for cancer patients in metropolitan, regional, rural and remote environments.
Cherie Seeliger is the Oncology Clinical Nurse Educator Allan Coates Cancer Centre Dubbo NSW. She has worked at the centre for 5 years and has led the education of nurses across the Northern Sector of Western NSW, including sites, Dubbo, Mudgee and Coonabarabran.
Cherie is passionate about providing nurses the education they require to ensure they have the knowledge to guide patients through their cancer journey. She is implementing an innovative model of delivering chemotherapy remotely using video to outreach clinics in Coonabarabran.
Oncology / Haematology 24 Hour Triage Rapid assessment and Access Tool Kit – Aussie Style Nationally!
Joan Thomas has worked in Cancer Care for 28 years. The past eight years in Australia and is currently the Nurse Unit Manager of the Chemotherapy Day Units & Research Trials Unit at Peninsula Health.
Joan brings expertise from the Greater Midlands Cancer Network Senior Nursing Team in the UK that worked with UKONS to develop the Oncology / Haematology 24 Hour Triage Rapid Assessment and Access Tool Kit and is now collaborating with a working party in Australia for the implementation of the tools.
Joan is a passionate advocate in the field of women's health and lead co-inventor of a medical device used internationally in gynaecological care.
We will be presenting some exciting data from our Immunotherapies course at the upcoming Cancer Nursing Society of Australia conference in June. We are seeing an incredible increase in understanding of immunotherapies – from 15% pre-module to 73% post-module! We are so pleased to be contributing to the safe, evidence based, best practice care of immunotherapy patients.
Taking at least one set of blood cultures instead of two sets prior to the first dose of antibiotics.
​ ANZCHOG: eviQ Education will be hosting a booth at the Australian and New Zealand Children's Haematology/Oncology Group (ANZCHOG) ASM from the 14-16 June in Sydney. Please drop by and say hello!
Facilitator training (online webinar): Register for our next online facilitator training on Thursday 14 June 2018 from 1.30pm – 3.30pm (EST). Please email us on eviqed@eviq.org.au to book your place and receive webinar login details.
Why can't I access or print my certificate?
eviQ Education is not a Learning Management System, we are just a normal website and don't track individual participation or results.
In the normal cellular environment, immune checkpoints are part of the body's self-protection system and help prevent autoimmunity. Immune checkpoint inhibitors are a cancer treatment which unleash the full force of the immune system by turning off the checkpoints and may cause immune related adverse events (irAEs). irAEs can affect any system, present at any time and can be life threatening. Head to module 3 to learn more about how to monitor patients for irAEs.